ReviewBioMed research international2013
Natural products and biological activity of the pharmacologically active cauliflower mushroom Sparassis crispa.
Review in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effects ofInternational journal of molecular sciences · 2018Pooled it
- A unique arsenic profile with unusual arsenic compounds discovered in the edible mushroom Sparassis crispa.Analytical and bioanalytical chemistry · 2026Article
- A Comprehensive Review of Bioactive Constituents, Health-Promoting Effects, Processing Technologies, and Industrial Applications ofFoods (Basel, Switzerland) · 2026Review
- Extracts from the Edible MushroomFoods (Basel, Switzerland) · 2026Article
- Study on Moisturizing Effect of Dendrobium officinale, Sparassis crispa, and Their Compound Extracts.Journal of cosmetic dermatology · 2025Article
- Inhibitory Activity ofJournal of microbiology and biotechnology · 2024Article
- Neuroprotective Effects ofJournal of fungi (Basel, Switzerland) · 2023Article
- De novo transcriptome assembly and comprehensive assessment provide insight into fruiting body formation of Sparassis latifolia.Scientific reports · 2022Article
- Research on Extraction, Structure Characterization and Immunostimulatory Activity of Cell Wall Polysaccharides fromPolymers · 2022Article
- Effects ofFrontiers in nutrition · 2022Article
- A review of the therapeutic and biological effects of edible and wild mushrooms.Bioengineered · 2021Review
- Recent advances in enzymatic synthesis of β-glucan and cellulose.Carbohydrate research · 2021Review
- Occurrence, behavior, and human exposure and health risks of potentially toxic elements in edible mushrooms with focus on Africa.Environmental monitoring and assessment · 2021Review
- Promising Potential of Crude Polysaccharides fromNutrients · 2021Article
- Evaluation of Polish wild Mushrooms as Beta-Glucan Sources.International journal of environmental research and public health · 2020Article
- Alginate-Derived Elicitors Enhance β-Glucan Content and Antioxidant Activities in Culinary and Medicinal Mushroom,Journal of fungi (Basel, Switzerland) · 2020Article
- Ultrasonic-assisted enzymatic extraction ofRSC advances · 2020Article
- The complete mitochondrial genome of an edible mushroom,Mitochondrial DNA. Part B, Resources · 2020Article
- Mushrooms-Rich Preparations on Wound Healing: From Nutritional to Medicinal Attributes.Frontiers in pharmacology · 2020Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sparassis crispa, also known as cauliflower mushroom, is an edible mushroom with medicinal properties. Its cultivation became popular in Japan about 10 years ago, a phenomenon that has been attributed not only to the quality of its taste, but also to its potential for therapeutic applications. Herein, I present a comprehensive summary of the pharmacological activities and mechanisms of action of its bioactive components, such as beta-glucan, and other physiologically active substances. In particular, the immunomodulatory mechanisms of the beta-glucan components are presented herein in detail.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.